← FDA Drug Approvals (Drugs@FDA)

SPRITAM

NDA · New Drug Application · Sponsor: APRECIA PHARMS · Approved 2015-07-31

Drug application

FDA Application #

NDA207958

Application type

New Drug Application

Brand name

SPRITAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Discontinued

Sponsor

APRECIA PHARMS

Manufacturer

Prasco Laboratories

First approval

2015-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown